In vivo and in vitro interaction of flunarizine with D-Fenfluramine serotonergic effects

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 1, 1996, Pages 155-161

  Mennini, T ^a   Gobbi, M ^a   Crespi, D ^a   Cinquanta, M ^a   Frittoli, E ^a   Giorcelli, P ^a   Anelli, M ^a   Caccia, S ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Calcium calmodulin protein kinase activity; D Fenfluramine; D Norfenfluramine; Dopamine release; Flunarizine; in ole levels and release; Methiothepin; Trifluperazine

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DEXFENFLURAMINE; DOPAMINE; DRUG METABOLITE; FLUNARIZINE; HALOPERIDOL; INDOLE; METITEPINE; NORFENFLURAMINE; PROTEIN KINASE (CALCIUM,CALMODULIN); RADIOISOTOPE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRIFLUOPERAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DEPLETION; DEPOLARIZATION; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG BRAIN LEVEL; DRUG METABOLISM; ENZYME ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM;

EID: 0029972413     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02010-1     Document Type: Article

References (40)

1. Achilli, G.; Perego, C.; Ponzio, F. Application of the dual-cell coulometric detector: A method for assaying monoamines and their metabolites. Anal. Biochem. 148:1-9; 1985.
2. Borroni, E.; Ceci, A.; Garattini, S.; Mennini, T. Differences between D-fenfluramine and D-norfenfluramine in serotonin presynaptic mechanisms. J. Neurochem. 40:891-893; 1983.
3. Caccia, S.; Anelli, M.; Ferrarese, A.; Fracasso, C.; Garattini, S. Single-and multiple-dose kinetics of D-fenfluramine in rats given anorectic and toxic doses. Xenobiotica 22:217-226; 1992.
4. Caccia, S.; Anelli, M.; Ferrarese, A.; Fracasso, C.; Garattini, S. The role of D-norfenfluramine in the indole-depleting effect of D-fenfluramine in the rat. Eur. J. Pharmacol. 233:71-77; 1993.
5. Caccia, S.; Sarati, S.; Anelli, M.; Garattini, S. Effect of escalating doses of D-fenfluramine on the content of indoles in brain. Neuropharmacol. 31:875-879; 1992.
6. 1 receptors. Eur. J. Pharmacol. Mol. Pharmacol. Section 266:131-138; 1994.
7. Fadda, F.; Gessa, G. L.; Mosca, E.; Stefanini, E. Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain. J. Neural Transm. 75:195-200; 1989.
8. Finnegan, K. T.; Calder, L.; Clikeman, J.; Wei, S.; Karler, R. Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats. Brain Res. 603:134-138; 1993.
9. 3H]5-HT release from rat hippocampal synaptosomes. Neuropharmacology 33: 833-835; 1994.
10. Garattini, S.; Bizzi, A.; Caccia, S.; Mennini, T. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Int. J. Obesity 16:S43-S50; 1992.
11. Garattini, S.; Mennini, T.; Samanin, R. From fenfluramine racemate to D-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake. Ann. NY Acad. Sci. 499:156-166; 1987.
12. Gardier, A. M.; Kaakkola, S.; Erfurth, A.; Wurtman, R. J. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Brain Res. 588:67-74; 1992.
13. Ghezzi, D.; Samanin, R.; Bernasconi, S.; Tognoni, G.; Gerna, M.; Garattini, S. Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in rats. Eur. J. Pharmacol. 24:205-210; 1973.
14. 3H]serotonin. Naunyn Schmiedebers Arch. Pharmacol. 345:1-6; 1992.
15. 3H]5-hydroxytryptamine induced by D-fenfluramine in rat hippocampal synaptosomes. Eur. J. Pharmacol. 238:9-17; 1993.
16. 3H]fenfluramine binding to rat brain: Biochemical and autoradiographic studies. J. Pharm. Pharmacol. 41:253-256; 1989.
17. Gray, E. G.; Whittaker, V. P. The isolationof nerve endings from brain: An electron-microcsope study of cell fragments derived by homogenization and centrifugation. J. Anat. 96:79-87; 1962.
18. Henderson, M. G.; Perry, K. W.; Fuller, R. W. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and B, B-difluoro-p-chloroamphetamine in rats. J. Pharmacol. Exp. Ther. 267:417-424; 1993.
19. Invernizzi, R.; Fracasso, C.; Caccia, S.; Di Clemente, A.; Garattini, S.; Samanin, R. Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and D-fenfluramine in rats. Relation to brain drug concentrations. Eur. J. Pharmacol. 163:77-83; 1989.
20. Johnson, M.; Mitros, K.; Stone, D. M.; Zobrist, R.; Hanson, G. R.; Gibb, J. W. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 261:586-591; 1992.
21. Kleven, M. S.; Seiden, L. S. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res. 505: 351-353; 1989.
22. +-evoked release of 5-hydroxytryptamine from superfused synaptosomes. Neuropharmacology 22:1095-1099; 1983.
23. Lugnier, C.; Follenius, A.; Gerard, D.; Stoclet, J. C. Bepridil and flunarizine as calmodulin inhibitors. Eur. J. Pharmacol. 98: 157-158; 1984.
24. 1B) receptor and rotationally restricted analog of RU-24,969. In: Fozard, J. R.; Saxena, P. R. , eds. Serotonin: Molecular biology, receptors and functional effects. Basel: Birkhauser Verlag; 1991:449-459.
25. Maura, G.; Gemignani, A.; Versace, P.; Martire, M.; Raiteri, M. Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings. Neurochem. Int. 4:219-224; 1982.
26. Mennini, T.; Bizzi, A.; Caccia, S.; Codegoni, A.; Fracasso, C.; Frittoli, E.; Guiso, G.; Martin Padura, I.; Taddei, C.; Uslenghi, A.; Garattini, S. Comparative studies on the anorectic activity of D-fenfluramine in mice, rats and guinea-pigs. Naunyn Schmiedebers Arch. Pharmacol. 343:483-490; 1991.
27. Mennini, T.; Borroni, E.; Samanin, R.; Garattini, S. Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem. Int. 3: 289-294; 1981.
28. 3H]D-fenfluramine binding to rat brain. Neurochem. Int. 13:345-351; 1988.
29. Raiteri, M.; Angelini, F.; Levi, G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25:411-414; 1974.
30. Ricaurte, G. A.; Molliver, M. E.; Martello, M. B.; Katz, J. L.; Wilson, M. A.; Martello, A. L. Dexfenfluramine neurotoxicity in brains of nonhuman primates. Lancet 338:1487; 1991.
31. Sabol, K. E.; Richards, J. B.; Seiden, L. S. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585:421-424; 1992.
32. Samanin, R.; Caccia, S.; Bendotti, C.; Borsini, F.; Borroni, E.; Invernizzi, R.; Pataccini, R.; Mennini, T. Further studies on the mechanism of serotonin-dependent anorexia in rats. Psychopharmacology 68:99-104; 1980.
33. Schmidt, C. J.; Kehne, J. H. Neurotoxicity of MDMA: Neurochemical effects. Ann. NY Acad. Sci. 600:665-681; 1990.
34. Steranka, L. R.; Sanders-Bush, E. Long-term effects of fenfluramine on central serotonergic mechanisms. Neuropharmacology 18:895-903; 1979.
35. Taylor, D. P.; Yevich, J. P.; Dextraze, P.; Moon, S. L.; Behling, S. H.; Defnet, J.; Geissler, M. Sigma ligands: A role in neuroprotection? In: Kamenka, J. M.; Domino, E. F., eds. Multiple sigma and PCP receptor ligands: Mechanisms for neuromodulation and neuroprotection? Ann Arbor, MI: NPP Books; 1992:767-778.
36. Walaas, S. I.; Nairn, A. C.; Greengard, P. Regional distribution of calcium-and cyclic adenosine 3′:5′-monophosphate-regulated protein phosphorylation systems in mammalian brain. I. Particulate systems. J. Neurosci. 3:302-311; 1983.
37. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; De Costa, B.; Rice, K. C. Sigma receptors: Biology and function. Pharmacol. Rev. 42:355-402; 1990.
38. Attuazione della Direttiva 86/609/CEE in materia di protezione degli animali utilizzati ai fini sperimentali o ad altri fini scientifici. Decreto legislativo del 27 Gennaio 1992. Gazzetta Ufficiale della Repubblica Italiana suppl. ord. N. 40, 18 Febbraio 1992.
39. EEC Council. Directive 86/609 on the Approximation of Laws, Regulations and Administrative Provisions Regarding the Protection of Animals used for Experimental and other Scientific Purposes. O.J.L.358,1, December 12, 1987.
40. NIH. Guide for the care and use of laboratory animals. National Institute of Health, Bethesda, NIH publ. no. 85-23. 1985.